We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.86B
AUM Growth
-$168M
Cap. Flow
-$326M
Cap. Flow %
-3.31%
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64

Top Buys

Rank Stock Value
1
JJSF icon
J&J Snack Foods
JJSF
+$29.7M
2
WDFC icon
WD-40
WDFC
+$28.7M
3
CBZ icon
CBIZ
CBZ
+$27.6M
4
EXPO icon
Exponent
EXPO
+$19.4M
5
ANDG
Andersen Group
ANDG
+$19.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.96%
2 Technology 18.79%
3 Financials 16.43%
4 Consumer Discretionary 12.93%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBBY
501
Bed Bath & Beyond
BBBY
$472M
$3.88M 0.04%
710,035
-81,965
-10% -$595K
CIX icon
502
Comp X International
CIX
$350M
$3.86M 0.04%
166,074
UL icon
503
Unilever
UL
$141B
$3.84M 0.04%
58,666
-1
-0% -$67
NEWT icon
504
NewtekOne
NEWT
$423M
$3.83M 0.04%
337,544
SNA icon
505
Snap-on
SNA
$21.2B
$3.79M 0.04%
11,000
-500
-4% -$171K
LRN icon
506
Stride
LRN
$3.53B
$3.78M 0.04%
58,238
+37,896
+186% +$3.44M
LGIH icon
507
LGI Homes
LGIH
$1.33B
$3.77M 0.04%
87,729
+30,461
+53% +$1.43M
BHRB icon
508
Burke & Herbert Financial Services Corp
BHRB
$1.47B
$3.74M 0.04%
59,995
-15,645
-21% -$981K
STEL
509
DELISTED
Stellar Bancorp
STEL
$3.74M 0.04%
120,797
-11,642
-9% -$358K
SIGA icon
510
SIGA Technologies
SIGA
$233M
$3.73M 0.04%
611,019
-69,203
-10% -$492K
MYGN icon
511
Myriad Genetics
MYGN
$507M
$3.72M 0.04%
605,000
-65,000
-10% -$471K
KRUS icon
512
Kura Sushi USA
KRUS
$568M
$3.72M 0.04%
71,015
-11,502
-14% -$627K
LAB icon
513
Standard BioTools
LAB
$351M
$3.69M 0.04%
2,885,529
+80,810
+3% +$109K
INGN icon
514
Inogen
INGN
$174M
$3.69M 0.04%
549,470
-51,498
-9% -$386K
NCNO icon
515
nCino
NCNO
$2.01B
$3.68M 0.04%
+143,548
New +$3.65M
REPX icon
516
Riley Exploration Permian
REPX
$727M
$3.67M 0.04%
139,042
-35,876
-21% -$954K
CWH icon
517
Camping World
CWH
$400M
$3.66M 0.04%
376,286
-45,673
-11% -$566K
CINT icon
518
CI&T Inc
CINT
$414M
$3.62M 0.04%
888,221
+364,696
+70% +$1.66M
MPB icon
519
Mid Penn Bancorp
MPB
$976M
$3.45M 0.04%
111,222
-7,321
-6% -$216K
SRI icon
520
Stoneridge
SRI
$200M
$3.43M 0.03%
591,741
-443,956
-43% -$2.79M
RXO icon
521
RXO
RXO
$3.39B
$3.41M 0.03%
+270,000
New +$3.98M
KFRC icon
522
Kforce
KFRC
$1.01B
$3.41M 0.03%
110,347
-23,476
-18% -$691K
RRC icon
523
Range Resources
RRC
$9.24B
$3.41M 0.03%
96,600
+16,600
+21% +$618K
DGICA icon
524
Donegal Group Class A
DGICA
$732M
$3.39M 0.03%
169,853
+144,853
+579% +$2.84M
FCX icon
525
Freeport-McMoran
FCX
$91.2B
$3.35M 0.03%
66,000
-24,000
-27% -$1.04M

Similar funds

Royce & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.

  • Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
  • Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
  • Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
  • Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
  • Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.